- Home
- HROW
HROW
Harrow Inc.
as 11-15-2024 3:35pm EST
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | NASHVILLE |
| Market Cap: | 1.9B | IPO Year: | N/A |
| Target Price: | $55.00 | AVG Volume (30 days): | 696.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.94 | EPS Growth: | N/A |
| 52 Week Low/High: | $8.26 - $59.23 | Next Earning Date: | 11-13-2024 |
| Revenue: | $169,138,000 | Revenue Growth: | 48.15% |
| Revenue Growth (this year): | 58.5% | Revenue Growth (next year): | 48.62% |
Latest Harrow Inc. News
HROW Breaking Stock News: Dive into HROW Ticker-Specific Updates for Smart Investing
Business Wire
a day ago
Harrow Announces Participation in Upcoming Investor Conferences
GuruFocus.com
2 days ago
Harrow Inc (HROW) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ...
Business Wire
3 days ago
Harrow Announces Third Quarter 2024 Financial Results
GuruFocus.com
3 days ago
Harrow Inc (HROW) Q3 2024 Earnings Report Preview: What To Look For
Business Wire
3 days ago
Harrow Launches Access and Affordability Program with Price Reductions for Branded Products
Business Wire
4 days ago
Harrow Announces Market Access Wins for VEVYE®
Business Wire
9 days ago
Harrow Partners with Asembia to Enhance Provider and Patient Experience Through Nationwide Digital Services and Hub Support for Harrow’s Branded Eyecare Products
Business Wire
16 days ago
Harrow To Report Third Quarter 2024 Financial Results After Market Close on November 13, 2024
Compare HROW vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HROW Harrow Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.